Washington Post Publisher Will Lewis Steps Down After Layoffs 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Instagram Outage Disrupts Thousands of U.S. Users 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
From 11 May 2017, American Depository Receipts (ADRs) in Statoil (OSE: STL, NYSE: STO) listed on the New York Stock Exchange will be traded ex-dividend USD 0.2201 and ex rights to participate in the dividend issue (scrip dividend programme) for fourth quarter 2016.
From 12 May 2017, the shares in Statoil at Oslo Stock Exchange (Oslo Børs) will be traded ex dividend USD 0.2201 and ex rights to participate in the dividend issue (scrip dividend programme) for fourth quarter 2016.
Record date at New York Stock Exchange and Oslo Børs is 15 May 2017.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
